PLX

Protalix BioTherapeutics (DE) (PLX)

About Protalix BioTherapeutics (DE) (PLX)

Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.

Details

Daily high
$2.72
Daily low
$2.62
Price at open
$2.69
52 Week High
$2.76
52 Week Low
$0.82
Market cap
195.9M
Dividend yield
0.00%
Volume
566,166
Avg. volume
646,886
P/E ratio
-18.71

Protalix BioTherapeutics (DE) News

Details

Daily high
$2.72
Daily low
$2.62
Price at open
$2.69
52 Week High
$2.76
52 Week Low
$0.82
Market cap
195.9M
Dividend yield
0.00%
Volume
566,166
Avg. volume
646,886
P/E ratio
-18.71